Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-17

FDA Approved: JAVYGTOR — Supplemental Application (Dr. Reddys Laboratories Inc)

View source ↗

Summary

FDA approved a supplemental application for JAVYGTOR (sapropterin dihydrochloride) from Dr. Reddy's Laboratories, updating/expanding its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JAVYGTOR (Sapropterin dihydrochloride)

Snippet

SUPPL AP for JAVYGTOR (SAPROPTERIN DIHYDROCHLORIDE)